[PGD synthase inhibitors, possible therapeutic use for allergic asthma].
Matsushita
N
N
Rohto Pharmaceutical Co., Ltd., Pharmaceutical R & D Division, Osaka, Japan. matusita@rohto.co.jp
D000818:Animals; D018926:Anti-Allergic Agents / Q000494:pharmacology; D018927:Anti-Asthmatic Agents / Q000494:pharmacology; D006801:Humans; D019746:Intramolecular Oxidoreductases / Q000037:antagonists & inhibitors* / Q000502:physiology; D054834:Lipocalins; D010880:Piperidines / Q000494:pharmacology
C116322:4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine; D018926:Anti-Allergic Agents; D018927:Anti-Asthmatic Agents; D054834:Lipocalins; D010880:Piperidines; D019746:Intramolecular Oxidoreductases; C022466:prostaglandin R2 D-isomerase